JASMINE SCOTT-STERLING: Open Payments
NPI 1033357728 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,010 in 10 payments from 8 companies in 2025. Trend: 2023 $433 · 2024 $1,025 · 2025 $1,010
Food & beverage: $1,010
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 2 | $247 |
| Novo Nordisk Inc | 2 | $174 |
| Alnylam Pharmaceuticals Inc. | 1 | $141 |
| Actelion Pharmaceuticals US, Inc. | 1 | $116 |
| Gilead Sciences, Inc. | 1 | $110 |
| Viatris Specialty LLC | 1 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $71 |
| AstraZeneca Pharmaceuticals LP | 1 | $44 |
Products named: TZIELD, Wegovy, AMVUTTRA, UPTRAVI, Epclusa, YUPELRI.
Industry payments across FL — which companies pay providers there.
